Developmental cigarette smoke exposure: Liver proteome profile alterations in low birth weight pups

Toxicology

Volumn 300, Issue 1-2, 2012, Pages 1-11

  Canales, Lorena ^a   Chen, Jing ^a   Kelty, Elizabeth ^a   Musah, Sadiatu ^a   Webb, Cindy ^a   Pisano, M Michele ^a   Neal, Rachel E ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

CSE; Developmental cigarette smoke exposure; Liver; Proteome

Indexed keywords

AMINO ACID; CIGARETTE SMOKE; COTININE; GLUCOSE; GLUTATHIONE TRANSFERASE; LIPID; LIVER PROTEIN; PEROXIREDOXIN;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CHRONIC CIGARETTE SMOKE EXPOSURE; DRUG METABOLISM; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; FEMALE; GESTATION PERIOD; GLUCONEOGENESIS; GLUCOSE METABOLISM; INFLAMMATION; LIPID METABOLISM; LIVER TOXICITY; LOW BIRTH WEIGHT; MALE; MATERNAL SMOKING; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOLECULAR SIZE; MOUSE; NONHUMAN; PERINATAL PERIOD; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GLUCONEOGENESIS; INHALATION EXPOSURE; LIVER; MALE; MASS SPECTROMETRY; METABOLOME; MICE; MICE, INBRED C57BL; PROTEOME; TOBACCO SMOKE POLLUTION;

EID: 84863842014     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.04.016     Document Type: Article

References (40)

1. American Lung Association, 2010. Secondhand Smoke Fact Sheet. (accessed 13.05.10). http://www.lungusa.org/.
2. Attwood P.V., Keech D.B. Pyruvate carboxylase. Curr. Top. Cell. Regul. 1984, 23:1-55.
3. Benkovic S.J., de Maine M.M. Mechanism of action of fructose 1,6-bisphosphatase. Adv. Enzymol. Relat. Areas Mol. Biol. 1982, 53:45-82.
4. Boyland E., Chasseaud L.F. The role of glutathione and glutathione S-transferases in mercapturic acid biosynthesus. Adv. Enzymol. 1969, 32:173-219.
5. Bradford M. Anal. Biochem. 1976, 72:248.
6. Centers for Disease Control and Prevention, 2001. Women and smoking. Surgeon General's Report. U.S. Department of Health and Human Services Coordinating Center for Health Promotion National Center for Chronic Disease Prevention and Health Promotion Office of Smoking and Health.
7. Centers for Disease Control and Prevention, 2010. Reproduction and Birth Outcomes. Low Birth Weight and Growth Retardation in the Environment (retrieved 12.05.10).
8. Chen J.W., Dodia C., Feinstein S.I., Jain M.K., Fisher A.B. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J. Biol. Chem. 2000, 275(37):28421-28427.
9. Comhair S.A., Erzurum S.C. Antioxidant responses to oxidant-mediated lung disease. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 283(2):L246-L255.
10. Deltour L., Foglio M.H., Duester G. Impaired retinol utilization in Adh4 alcohol dehydrogenase mutant mice. Dev. Genet. 1999, 25(1):1-10.
11. Eschrich K., Herzog B. Fructose-1,6-bisphosphatase. Wiley Encyclopedia of Molecular Medicine 2002, John Wiley & Sons, Inc.
12. Esposito E.R., Horn K.H., Greene R.M., Pisano M.M. An animal model of cigarette smoke-induced in utero growth retardation. Toxicology 2008, 246:193-202.
13. Gancedo J.M., Gancedo C. Fructose-1,6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non-fermenting yeasts. Arch. Mikrobiol. 1971, 76:132-138.
14. Han X., Gubitosi-Klug R.A., Collins B.J., Gross R.W. Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. Biochemistry 1996, 35(18):5822-5832.
15. Hayhurst G.P., Lee Y., Lambert G., Ward J.M., Gonzales F.J. Hepatocyte nuclear factor 4 α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol. 2001, 21(4):1393-1403.
16. Hertz R., Magenheim J., Berman I., Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 1998, 392:512-516.
17. Ingenuity Systems, 2010. Ingenuity Pathway Analysis: Overview. (accessed 27.10.10). http://www.ingenuity.com/products/pathways_analysis.html.
18. Izzotti A., Balansky R.M., Cartiglia C., Camoirano A., Longobardi M., De Flora S. Genomic and transcriptional alterations in mouse fetus liver after transplacental exposure to cigarette smoke. FASEB J. 2003, 17(9):1127-1129.
19. Jakoby W.B. The glutathione S-transferases: a group of multifunctional detoxification proteins. Adv. Enzymol. Relat. Areas Mol. Biol. 1978, 46:383-414.
20. Jimenez-Marin A., Collado-Romero M., Ramirez-Boo C., Garrido J.J. Biological pathway analysis by ArrayUnlock and Ingenuity Pathway Analysis. BMC Proc. 2009, 1-6.
21. Karp N.A., Griffin J.L., Lilley K.S. Application of partial least squares discriminant analysis to two-dimensional difference gel studies in expression proteomics. Proteomics 2005, 5:81-90.
22. Koren G., Klein J., Forman R., Graham K., Phan M.K. Biological markers of intrauterine exposure to cocaine and cigarette smoking. Dev. Pharmacol. Ther. 1992, 18:228-236.
23. Lee L.H., Shui G., Farooqui A.A., Wenk M.R., Tan C.H., Ong W.Y. Lipidomic analyses of the mouse brain after antidepressant treatment: evidence for endogenous release of long-chain fatty acids?. Int. J. Neuropsychopharmacol. 2009, 12(7):953-964.
24. Manevich Y., Fisher A. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radical Biol. Med. 2005, 38:1422-1432.
25. Maton A., Hopkins J., McLaughlin C.W., Johnson S., Warner M.C., LaHart D., Wright J.D. Human Biology and Health 1993, Prentice Hall, Englewood Cliffs, NJ, USA.
26. Mendelsohn C., Lohnes D., Decimo D., Lufkin T., LeMeur M., Chambon P., Mark M. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 1994, 120:2749-2771.
27. Mueckler M. Facilitated glucose transporters. Eur. J. Biochem. 1994, 219:713-725.
28. National Toxicology Program Report on Carcinogens 2005, U.S. Department of Health and Human Services, Public Health Service. 11th ed.
29. Neuhoff V., Stamm R., Eibl H. Clear background and highly sensitive protein staining with Coomassie Blue dyes in polyacrylamide gels: a systematic analysis. Electrophoresis 1985, 6:427-448.
30. Newsholme E.A., Leech A.R. Biochemistry for the Medical Sciences 1985, John Wiley and Sons, Chichester.
31. Pappin D.J., Hojrup P., Bleasby A.J. Rapid identification of proteins by peptide-mass fingerprinting. Curr. Biol. 1993, 3:327-332.
32. Payne J., Morris J.G. Pyruvate carboxylase in Rhodopseudomonas spheroides. J. Gen. Microbiol. 1969, 59:97-101.
33. Rudel L., Lee R.G., Parini P. ACAT2 is a target for treatment of coronary heart disease associated with hypercholerolemia. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1112-1118.
34. Substance Abuse and Mental Health Services Administration, 1999. Office of Applied Studies. National Household Survey on Drug Abuse.
35. Teague S.V., Pinkerton K.E., Goldsmith M., Gebremichael A., Chang S. Sidestream Cigarette Smoke Generation and Exposure System for Environmental Tobacco Smoke Studies. Inhalation Toxicology 1994, Taylor & Francis.
36. Tomatis, L., 1989. Overview of perinatal and multigeneration carcinogenesis. In: Napapkov, N.P., Rice, J.M., Tomatis, L., Yamasaki, H. (Eds.), Prenatal and Multigeneration Carcinogenesis. International Agency for Research on Cancer Sci. Publ. No. 96, Lyon France, pp. 1-15.
37. U.S. Department of Health and Human Services, 2006. Office of the Surgeon General. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General (retrieved 12.05.10).
38. U.S. Department of Health and Human Services, 2010. Tobacco Use in America: Tobacco Product Brand Preferences. Office of Applied Studies. (accessed 27.10.10, Chapter 7). http://www.oas.samhsa.gov/nhsda/tobacco/chapter7.htm.
39. Valvanidis A., Vlachogianni T., Fiotakis K. Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int. J. Environ. Res. Public Health 2009, 6:445-462.
40. Zdravkovic T., Genbacev O., McMaster M.T., Fisher S.J. The adverse effects of maternal smoking on the human placenta: a review. Placenta 2005, 26:S81-S86.